Helix Announces Multi-Year Agreement with AstraZeneca to Support Genomic Research for Drug Discovery and Development
SAN MATEO, Calif., July 7, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics company, today announced a multi-year relationship with AstraZeneca, a global biopharmaceutical company. Under this agreement AstraZeneca will gain access to Helix's continuously growing, deeply...
SAN MATEO, Calif., July 7, 2026 /PRNewswire/ -- Helix, the leading enterprise genomics company, today announced a multi-year relationship with AstraZeneca, a global biopharmaceutical company. Under this agreement AstraZeneca will gain access to Helix's continuously growing, deeply...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.